Small RNAs — short stretches of genetic material — from microbes may be playing a role in rheumatoid arthritis and other autoimmune diseases.

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.

Vanderbilt scientists have discovered a new target for normalizing tumor blood vessels to improve cancer immunotherapies.

Howard Fuchs, MD, professor of Medicine, Division of Rheumatology and Immunology, died unexpectedly Oct. 28. He was 64.

Taylor Brumbelow has a gift for quickly putting people at ease.

Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.